COVID-19 IgG Antibody Detection Kit (CLIA)
The COVID-19 IgG Antibody Detection Kit (CLIA) is a chemiluminescence immunoassay intended for in vitro quantitative detection of novel coronavirus (SARS-CoV-2) IgG antibodies in human serum samples. It is used in combination with our Full-Automatic Chemiluminescence Immunoassay System (FACIS-I), to simplify the operation procedure and obtain quantitative results.